148 related articles for article (PubMed ID: 1652017)
1. 5-(5-Bromothien-2-yl)-2'-deoxyuridine and 5-(5-chlorothien-2-yl)-2'-deoxyuridine are equipotent to (E)-5-(2-bromovinyl)-2'-deoxyuridine in the inhibition of herpes simplex virus type I replication.
Wigerinck P; Pannecouque C; Snoeck R; Claes P; De Clercq E; Herdewijn P
J Med Chem; 1991 Aug; 34(8):2383-9. PubMed ID: 1652017
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antiviral activity of the enantiomeric forms of carba-5-iodo-2'-deoxyuridine and carba-(E)-5-(2-bromovinyl)-2'-deoxyuridine.
Balzarini J; Baumgartner H; Bodenteich M; De Clercq E; Griengl H
J Med Chem; 1989 Aug; 32(8):1861-5. PubMed ID: 2547072
[TBL] [Abstract][Full Text] [Related]
3. Phosphonoformate and phosphonoacetate derivatives of 5-substituted 2'-deoxyuridines: synthesis and antiviral activity.
Griengl H; Hayden W; Penn G; De Clercq E; Rosenwirth B
J Med Chem; 1988 Sep; 31(9):1831-9. PubMed ID: 2842506
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of 5-isoxazol-5-yl-2'-deoxyuridines exhibiting antiviral activity against HSV and several RNA viruses.
Lee YS; Park SM; Kim BH
Bioorg Med Chem Lett; 2009 Feb; 19(4):1126-8. PubMed ID: 19147352
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antiviral activity of 5-heteroaryl-substituted 2'-deoxyuridines.
Wigerinck P; Snoeck R; Claes P; De Clercq E; Herdewijn P
J Med Chem; 1991 Jun; 34(6):1767-72. PubMed ID: 2061920
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antiviral activity of (E)-5-(2-bromovinyl)uracil and (E)-5-(2-bromovinyl)uridine.
De Clercq E; Desgranges C; Herdewijn P; Sim IS; Jones AS; McLean MJ; Walker RT
J Med Chem; 1986 Feb; 29(2):213-7. PubMed ID: 3005566
[TBL] [Abstract][Full Text] [Related]
7. (E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent.
De Clercq E; Descamps J; De Somer P; Barr PJ; Jones AS; Walker RT
Proc Natl Acad Sci U S A; 1979 Jun; 76(6):2947-51. PubMed ID: 223163
[TBL] [Abstract][Full Text] [Related]
8. 2'-Fluorinated arabinonucleosides of 5-(2-haloalkyl)uracil: synthesis and antiviral activity.
Griengl H; Wanek E; Schwarz W; Streicher W; Rosenwirth B; De Clercq E
J Med Chem; 1987 Jul; 30(7):1199-204. PubMed ID: 3037079
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antiviral activity of the carbocyclic analogues of (E)-5-(2-halovinyl)-2'-deoxyuridines and (E)-5-(2-halovinyl)-2'-deoxycytidines.
Herdewijn P; De Clercq E; Balzarini J; Vanderhaeghe H
J Med Chem; 1985 May; 28(5):550-5. PubMed ID: 2985782
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antiviral properties of (E)-5-(2-bromovinyl)-2'-deoxycytidine-related compounds.
Jones AS; Sayers JR; Walker RT; De Clercq E
J Med Chem; 1988 Jan; 31(1):268-71. PubMed ID: 2826786
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of herpes simplex virus types 1 and 2 replication in vitro by mercurithio analogs of deoxyuridine.
Holliday J; Williams MV
Antiviral Res; 1991 Sep; 16(2):197-203. PubMed ID: 1665962
[TBL] [Abstract][Full Text] [Related]
12. Carbocyclic 5-iodo-2'-deoxyuridine (C-IDU) and carbocyclic (E)-5-(2-bromovinyl)-2'-deoxyuridine (C-BVDU) as unique examples of chiral molecules where the two enantiomeric forms are biologically active: interaction of the (+)- and (-)-enantiomers of C-IDU and C-BVDU with the thymidine kinase of herpes simplex virus type 1.
Balzarini J; De Clercq E; Baumgartner H; Bodenteich M; Griengl H
Mol Pharmacol; 1990 Mar; 37(3):395-401. PubMed ID: 2156153
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antiviral activity of the carbocyclic analogues of 5-ethyl-2'-deoxyuridine and of 5-ethynyl-2'-deoxyuridine.
Shealy YF; O'Dell CA; Arnett G; Shannon WM
J Med Chem; 1986 Jan; 29(1):79-84. PubMed ID: 3001308
[TBL] [Abstract][Full Text] [Related]
14. 5-(2-Chloroethyl)-2'-deoxyuridine: a potent and selective inhibitor of herpes viruses in vitro and in vivo.
Rosenwirth B; Griengl H; Wanek E; De Clercq E
Antiviral Res; 1985; Suppl 1():20-8. PubMed ID: 3002256
[No Abstract] [Full Text] [Related]
15. Herpes simplex virus type 1 that exhibits herpes simplex virus type 2 sensitivity to (E)-5-(2-bromovinyl)-2'-deoxyuridine.
Docherty JJ; Dobson AT; Trimble JJ; Jennings BA
Intervirology; 1991; 32(5):308-15. PubMed ID: 1657822
[TBL] [Abstract][Full Text] [Related]
16. 5-Substituted 2'-deoxyuridines which selectively inhibit herpes simplex virus replication.
De Clercq E
Adv Ophthalmol; 1979; 38():204-13. PubMed ID: 230717
[No Abstract] [Full Text] [Related]
17. 5-O-Alkylated derivatives of 5-hydroxy-2'-deoxyuridine as potential antiviral agents. Anti-herpes activity of 5-propynyloxy-2'-deoxyuridine.
Torrence PF; Spencer JW; Bobst AM
J Med Chem; 1978 Feb; 21(2):228-31. PubMed ID: 202709
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological activity of 5-(2,2-difluorocyclopropyl)-2'-deoxyuridine deoxyuridine diastereomers.
Tandon M; Singh S; Xu L; Kumar P; Wiebe LI; Knaus EE; Gati WP; Tempest ML
Drug Des Discov; 1992; 9(1):79-91. PubMed ID: 1333829
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of the diastereomers of 5-(2,2-dichlorocyclopropyl)- and 5-(2-chlorocyclopropyl)-2'-deoxyuridine, and the antiviral and cytotoxic activity of these and bromo analogues.
Tandon M; Singh S; Wiebe LI; Knaus EE; Gati WP; Tempest ML
Drug Des Deliv; 1991 Jul; 7(4):295-307. PubMed ID: 1657019
[TBL] [Abstract][Full Text] [Related]
20. Therapy of varicella-zoster virus infection--mechanism of action of (E)-5-(2-bromovinyl)-2'-deoxyuridine.
Shigeta S; Yokota T; De Clercq E
Antiviral Res; 1985; Suppl 1():35-44. PubMed ID: 3002264
[No Abstract] [Full Text] [Related]
[Next] [New Search]
